about
Recent Progress towards Novel EV71 Anti-Therapeutics and VaccinesAn Overview of Challenges Limiting the Design of Protective Mucosal Vaccines for FinfishA Review of the Immunological Mechanisms Following Mucosal Vaccination of FinfishOral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against TuberculosisMucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticlesIntranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challengeOral immunization of haemaggulutinin H5 expressed in plant endoplasmic reticulum with adjuvant saponin protects mice against highly pathogenic avian influenza A virus infection.Prospects for developing an effective particle-mediated DNA vaccine against influenza.Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection.Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthraxThe vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteersRSV fusion (F) protein DNA vaccine provides partial protection against viral infectionInfection of newborn piglets with Bordetella pertussis: a new model for pertussisImmune regulation by oral tolerance induces alternate activation of macrophages and reduces markers of plaque destabilization in Apobtm2Sgy/Ldlrtm1Her/J miceEnhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in miceSevere acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccineOral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen.Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administrationBinding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice.Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challengeVaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosisProbing local innate immune responses after mucosal immunisationNovel mucosal DNA-MVA HIV vaccination in which DNA-IL-12 plus cholera toxin B subunit (CTB) cooperates to enhance cellular systemic and mucosal genital tract immunitySpecific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.Construction and immunogenicity of recombinant adenovirus vaccines expressing the HMW1, HMW2, or Hia adhesion protein of nontypeable Haemophilus influenzaeLcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in miceEvaluation of an intranasal virosomal vaccine against respiratory syncytial virus in mice: effect of TLR2 and NOD2 ligands on induction of systemic and mucosal immune responses.Long term persistence of IgE anti-influenza virus antibodies in pediatric and adult serum post vaccination with influenza virus vaccine.Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidate.Antigen-Specific IgG ameliorates allergic airway inflammation via Fcγ receptor IIB on dendritic cells.Immune response induced by recombinant Mycobacterium bovis BCG producing the cholera toxin B subunit.Development of a biosafety enhanced and immunogenic Salmonella enteritidis ghost using an antibiotic resistance gene free plasmid carrying a bacteriophage lysis system.Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants.Protectivity conferred by immunization with intranasal recombinant outer membrane protein H from Pasteurella multocida serovar A:1 in chickens.Intranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plagueThe Influence of Immunization Route, Tissue Microenvironment, and Cytokine Cell Milieu on HIV-Specific CD8+ T Cells Measured Using Fluidigm Dynamic Arrays.
P2860
Q26775734-95679995-2C64-42F7-B322-3493AC178F2DQ26777943-50FE8941-F765-4A51-A9B4-AAD5A2776F3DQ26784475-36EE319C-84AC-4F64-B7B8-C8891EEF9388Q27313927-1D2AC2B6-1124-40EB-A09C-234426DFFFF6Q28187952-AB4D00CB-E9AE-49F2-8670-6F7FA9AA429EQ28394668-13F6A239-53AD-4E87-A4F1-3C9F1E426B6AQ28743895-E3B3CE6F-26E8-4D5D-A5E4-FFB7C2C9E7B3Q30365159-1A06EB40-EDC0-4E68-ABFC-A2D0448DD3E9Q30380300-1C93F396-9AC9-42B0-9222-B48D8A819048Q30384379-B3B74A45-AEF1-4C10-AF12-F95D70B8DEFEQ33396429-2E9257AC-3397-4533-A6CA-CEC4055D1A26Q33768926-8CF84FA1-6AB1-4236-A6BE-763B1A9EBE7EQ33775390-67DB2673-7F98-4BCD-88B9-332F3B6491D5Q33788175-0C56F884-9E81-4B3E-B510-F2C9725583B9Q33822640-C6911CD0-86BC-44EF-9B10-6D83DBF6C141Q33843895-31CC0516-99ED-41D6-87BF-5AF8BA1183A2Q33863306-CA82E996-D5F9-43E6-A065-E991742345BAQ33883273-78E36D97-B1F6-4301-B26C-B45A562D9C0EQ33958402-7CEDC104-07EF-4966-88DA-96C7127C2E08Q33962224-0B7E812B-052F-4489-B525-56F2262EC6C0Q34081625-2CD7B81D-529B-48E2-962C-9410C5FB68FDQ34113328-3FFC626B-844F-4B5B-83BB-6B1E1AAFC42EQ34122078-1D5896A5-1500-4F08-9E0E-616809BC002DQ34154378-6225434F-BDB4-4E88-BDFC-5063EB65E0DFQ34172564-54F9AEA6-A480-4E1D-B44A-EFF5CE9A7FD8Q34183386-94FF50BA-0919-419E-B588-5B1707BBA4D3Q34189901-57385398-6359-4367-846F-7A5713A9E1EDQ34298699-3C17522A-546A-4651-A141-4DDBC9DB1C96Q34357038-0163C301-1810-40E5-9985-30CFB4477AF1Q34580095-13B679C8-9987-4019-9D84-859E7754841CQ34674831-3AEB1588-AE46-4386-9794-C4C6A3A496A1Q34730017-811ED0F9-E802-4D9B-8476-A19C732BB922Q34738751-4E34939C-ED01-4A1C-AA10-DF48745E9498Q34817667-E4957F3F-8EFB-4602-812C-4C54AB525782Q34933032-52FA9123-D853-4D88-B79F-01C8B1849B12Q35036179-4BB92EF1-AEF2-487A-8F19-BE22947289BBQ35042482-2DCEE427-4EA0-49D6-972E-602D05C73C18Q35252487-272A3C0B-0470-4F6D-87CB-83CB65EDF5D1Q35530270-27E83121-FFB9-4D65-B95D-966E1ADD4E28Q35577620-E6D69BA7-9C80-4642-8EF3-8EFFFDD47EBB
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Vaccination strategies for mucosal immune responses
@ast
Vaccination strategies for mucosal immune responses
@en
type
label
Vaccination strategies for mucosal immune responses
@ast
Vaccination strategies for mucosal immune responses
@en
prefLabel
Vaccination strategies for mucosal immune responses
@ast
Vaccination strategies for mucosal immune responses
@en
P2093
P2860
P1476
Vaccination strategies for mucosal immune responses
@en
P2093
P2860
P304
P356
10.1128/CMR.14.2.430-445.2001
P407
P577
2001-04-01T00:00:00Z